Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Celularity

Biotech & Life Sciences · Florham Park, United States · Founded 2016 · IPO 2019 Unicorn

Clinical-stage biotechnology company productizing allogeneic cells and tissues derived from the postpartum placenta

Valuation
$94M
Market cap · May/2026
Revenue
$54M
Latest reported FY

Investors

8 investors on Celularity's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 7 investors entered at this stage
Tony Robbins
United Therapeutics
Celgene
Sorrento Therapeutics
Human Longevity
Bill Maris
Section 32
Series B+ 1 investor entered at this stage
Dragasac

Global footprint

Where Celularity has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States99.1%
🇸🇦 Saudi Arabia0.9%
2 countries shown
Web traffic by country
3.8K monthly visits
across markets
🇺🇸 United States94.7%
🇮🇳 India2.6%
Top 2 markets shown

Patent intelligence

$195M patent portfolio · 123 active families

Estimated portfolio value
$195M
208.8% of market cap · comparable to top peer Juno Therapeutics ($239M)
123 active patent families
Where Celularity innovates Cell biologyMolecular biologyStem cellPlacental cellBiophysics

Where Celularity concentrates vs peers

Each axis is a top-10 topic across Celularity and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Celularity

An AI-synthesized read of the highest-engagement posts about Celularity on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Celularity on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.